Tag: resection

FDA Clears Device to Remove Dead Pancreatic Tissue

The US Food and Drug Administration (FDA) has approved the EndoRotor System (Interscope, Inc) for removal of necrotic tissue in patients with walled-off pancreatic necrosis...

When and Why Do Diverticulitis Patients Need Surgery?

NEW YORK (Reuters Health) – An update to the American Society of Colon and Rectal Surgeons (ASCRS) guideline on diverticular disease suggests that surgery may...

Surveillance After CRC Resection Does Not Improve Survival

Intensive surveillance with carcinoembryonic antigen (CEA) testing and CT scans after colorectal cancer resection did not improve recurrence-free or overall survival when compared with standard...

Appendix May Be Common Site of Endometriosis

Among women who have a coincidental appendectomy during surgery for chronic pelvic pain or endometriosis, about 15% have appendiceal endometriosis confirmed by pathological examination, according...

Adjuvant Systemic Chemotherapy Tied to Better Survival After Resection of Colorectal Peritoneal Metastases

NEW YORK (Reuters Health) – Adjuvant systemic chemotherapy following resection of isolated synchronous colorectal peritoneal metastases is associated with improved survival compared with active surveillance,...

Outpatient Brain Tumor Surgery Feasible, Safe

As an ever-increasing number of complex surgeries are regularly being performed in an outpatient setting at ambulatory surgical centers, some brain tumor resections may be...

CRC With Peritoneal Metastases: CRS-HIPEC Refinements

Patients with colorectal cancer (CRC) who have peritoneal metastases should only be treated in a specialized referral center and given systemic chemotherapy before cytoreductive surgery...

Adding a Blood Test to Screening May Improve Cancer Detection

A minimally invasive multicancer blood test used with standard-of-care screening is safe, effective, and feasible for use in routine clinical care, according to interim findings...

Survival & NAC Use Continue to Increase

Uptake of neoadjuvant chemotherapy (NAC) for the treatment of advanced ovarian cancer has increased dramatically since 2006 in the United States, but importantly, the median...